Cromos Pharma, where the patients are

CROs/Service Providers

WuXi PharmaTech, Pharmacyclics to partner

Monday, November 18, 2013 01:48 PM

CRO WuXi PharmaTech, with operations in China and the U.S., said its subsidiary Shanghai SynTheAll (STA) Pharmaceutical has entered into a supply arrangement with Pharmacyclics. This follows a successful multiple-year development and clinical manufacturing partnership that supported Pharmacyclics with an expedited NDA submission and final approval by the FDA of Imbruvica  on Nov. 13, for treatment of patients with mantle cell lymphoma who have received at least one prior therapy.  This indication is based on overall response rate. An improvement in survival or disease-related symptoms has not been established. 

More... »

CRF Health eCOA webinar series

Quintiles launches Data-driven Trial Execution

Monday, November 18, 2013 01:33 PM

Quintiles has launched Data-driven Trial Execution, leveraging risk-based monitoring to improve clinical trial delivery.

More... »

Covance, NeoGenomics collaborate

Monday, November 18, 2013 01:31 PM

CRO Covance and NeoGenomics, a provider of oncology-focused genetics testing services, are collaborating to provide anatomic pathology and specialty laboratory testing services for global clinical trials.

More... »

Oncodesign, UCB collaborate on neurodegenerative diseases

Thursday, November 14, 2013 10:00 AM

Oncodesign, a drug discovery company and oncology pharmacology service provider, has entered into a research collaboration and exclusive license option with UCB, a global biopharmaceutical provider specialized in neurology and immunology. The collaboration will bring innovative therapeutic solutions to patients suffering from neurodegenerative disorders. Oncodesign will apply its Nanocyclix technology on a kinase target selected by UCB, with the aim of discovering potent and selective inhibitors that cross the blood brain barrier.

More... »

BioClinica completes first phase of big data research project

Thursday, November 14, 2013 09:30 AM

BioClinica, a global CRO specializing in technology-enhanced solutions for clinical trials, announced the successful completion of the first phase of a big data research project to develop novel algorithms for the automated analysis of medical images in clinical trials. This work was made possible by a strategic partnership with the Center for Dynamic Data Analytics (CDDA), a National Science Foundation (NSF) sponsored cooperative research center focused on developing scalable methods for handling large amounts of complex industry-related data.

More... »

Icon launches Iconik Labs

Wednesday, November 13, 2013 12:13 PM

Global CRO Iconhas launched Iconik Labs, the latest service to leverage its Iconik technology platform.

More... »

AMRI announces lifting of FDA warning letter

Wednesday, November 13, 2013 09:27 AM

Albany, N.Y.-based Albany Molecular Research (AMRI) has received a close-out letter from the FDA lifting a 2010 warning letter related to its Burlington, Mass., aseptic fill-and-finish facility.

More... »

Norwich Pharmaceuticals is now Norwich Pharma Services

Wednesday, November 13, 2013 09:21 AM

Norwich Pharmaceuticals, a New York-based provider of contract development and manufacturing services for the pharmaceutical and biotech industry, has changed its name to Norwich Pharma Services.

More... »

PRA to acquire CRI Lifetree, boosting global phase I presence

Wednesday, November 13, 2013 09:01 AM

PRA, a CRO based in Raleigh, N.C., intends to acquire privately held CRI Lifetree, a research organization that focuses on early stage, patient population studies.

More... »

Report: CRO market to top $30 billion by 2018

Monday, November 11, 2013 03:06 PM

A new report by healthcare sector corporate finance and strategy specialist Results Healthcare says the CRO sector is seeing a recovery, driven by improved optimism across the biopharma industry, the sector’s largest customer group, where many key CRO customers are now at the tail end of multi-year patent cliffs and are stepping up investments into their pipelines, particularly products in late-stage development.

More... »

CenterWatch Data Library



Browse by:


April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs